Table 1. Descriptive statistics.
| Males (n = 1,752) | Females (n = 1,748) | |||||
|---|---|---|---|---|---|---|
| Statin users (n = 253) |
Non-users (n = 1,499) |
P | Statin users (n = 171) |
Non-users (n = 1,577) |
P | |
| Age (years) | 66 (57; 72) | 50 (40; 61) | < .0001 | 65 (59; 71) | 50 (40; 60) | < .0001 |
| BMI (kg/m2) | 29.38 (26.97; 31.78) | 27.80 (25.30; 30.60) | < .0001 | 28.93 (26.29; 32.67) | 25.96 (23.08; 29.76) | < .0001 |
| Hypertension (%) | 87.7 | 49.4 | < .0001 | 74.3 | 33.3 | < .0001 |
| Myocardial infarction (%) | 21.3 | 1.4 | < .0001 | 4.1 | 0.4 | < .0001 |
| Diabetes mellitus (%) | 29.6 | 7.1 | < .0001 | 22.8 | 4.9 | < .0001 |
| Diastolic BP (mmHg) | 77 (71; 84) | 81 (75; 88) | < .0001 | 76 (70; 81) | 76 (70; 82) | 0.6744 |
| Systolic BP (mmHg) | 134 (124; 144) | 133 (123; 144) | 0.6503 | 127 (117; 139) | 120 (110; 132) | < .0001 |
| LDL (mmol/l) | 2.64 (2.18; 3.19) | 3.58 (2.98; 4.18) | < .0001 | 2.97 (2.55; 3.53) | 3.40 (2.79; 4.12) | < .0001 |
| TG (mmol/l) | 1.72 (1.21; 2.54) | 1.50 (1.01; 2.30) | 0.002 | 1.47 (1.11; 1.96) | 1.18 (0.84; 1.68) | < .0001 |
| Chol (mmol/l) | 4.50 (3.90; 5.20) | 5.60 (4.80; 6.30) | < .0001 | 5.20 (4.60; 5.80) | 5.60 (4.90; 6.31) | < .0001 |
| Smoking (%) | 14.2 | 25.2 | 9.9 | 22.7 | ||
| VO2max (ml/min) | 1922 (1573; 2237) | 2450 (2062; 2868) | < .0001 | 1400 (1159; 1600) | 1600 (1366; 1870) | < .0001 |
| VO2@AT (ml/min) | 1050 (850; 1200) | 1200 (1000; 1400) | < .0001 | 800 (700; 950) | 900 (800; 1000) | < .0001 |
| O2HRmax (ml/beat) | 14.6 (12.8; 16.7) | 15.7 (13.8; 17.9) | < .0001 | 10.7 (9.5; 12.2) | 10.5 (9.3; 12.0) | 0.2635 |
| Beta Blocker (%) | 60.1 | 16.3 | < .0001 | 53.8 | 18.7 | < .0001 |
| Calcium Channel Blockers (%) | 17 | 3.3 | < .0001 | 7.6 | 2.4 | < .0001 |
| Angiotensin-converting enzyme blockers (%) | 47 | 10.5 | < .0001 | 25.7 | 7.2 | < .0001 |
| Physical inactivity (%) | 41.9 | 38.4 | 0.2952 | 32.7 | 35.38 | 0.4932 |
| eGFR | 79.5 (67.4; 90.7) | 89.46 (78.5; 101.8) | < .0001 | 75.1 (64.1; 85.6) | 85.2 (74.1; 99.6) | < .0001 |